Market capitalization | $7.46b |
Enterprise Value | $12.72b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 29.93 |
EV/Sales (TTM) EV/Sales | 2.83 |
P/S ratio (TTM) P/S ratio | 1.66 |
P/B ratio (TTM) P/B ratio | 1.26 |
Revenue growth (TTM) Revenue growth | 3.74% |
Revenue (TTM) Revenue | $4.49b |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
13 Analysts have issued a Elanco Animal Health, Inc. forecast:
13 Analysts have issued a Elanco Animal Health, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 4,492 4,492 |
4%
4%
|
|
Gross Profit | 1,937 1,937 |
1%
1%
|
|
EBITDA | 972 972 |
6%
6%
|
EBIT (Operating Income) EBIT | 300 300 |
15%
15%
|
Net Profit | -1,255 -1,255 |
1,194%
1,194%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Elanco Animal Health, Inc. engages in the innovation, development, manufacture and market products for companion and food animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded on May 3, 2018 and is headquartered in Greenfield, IN.
Head office | United States |
CEO | Jeffrey Simmons |
Employees | 9,800 |
Founded | 1954 |
Website | www.elanco.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.